Q1 2025 EPS Estimates for Phibro Animal Health Co. Lifted by Zacks Research (NASDAQ:PAHC)

Phibro Animal Health Co. (NASDAQ:PAHC) – Research analysts at Zacks Research lifted their Q1 2025 earnings estimates for shares of Phibro Animal Health in a research report issued on Wednesday, September 11th. Zacks Research analyst R. Department now anticipates that the company will post earnings of $0.20 per share for the quarter, up from their previous estimate of $0.19. The consensus estimate for Phibro Animal Health’s current full-year earnings is $1.48 per share. Zacks Research also issued estimates for Phibro Animal Health’s Q2 2025 earnings at $0.39 EPS, Q3 2025 earnings at $0.35 EPS, Q4 2025 earnings at $0.37 EPS, FY2025 earnings at $1.31 EPS, Q1 2026 earnings at $0.39 EPS, Q2 2026 earnings at $0.37 EPS, Q3 2026 earnings at $0.34 EPS, Q4 2026 earnings at $0.35 EPS, FY2026 earnings at $1.45 EPS and FY2027 earnings at $2.05 EPS.

Other analysts have also recently issued research reports about the company. Bank of America upped their price objective on Phibro Animal Health from $13.00 to $15.00 and gave the company an “underperform” rating in a research note on Friday, August 30th. JPMorgan Chase & Co. assumed coverage on Phibro Animal Health in a research report on Tuesday. They set a “neutral” rating and a $22.00 price target on the stock. Three investment analysts have rated the stock with a sell rating, two have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat, Phibro Animal Health currently has a consensus rating of “Hold” and a consensus price target of $15.00.

Phibro Animal Health Stock Performance

Shares of PAHC stock opened at $21.99 on Thursday. The stock has a market capitalization of $890.60 million, a price-to-earnings ratio of 68.72, a PEG ratio of 1.60 and a beta of 0.52. Phibro Animal Health has a one year low of $9.40 and a one year high of $22.31. The company’s 50-day simple moving average is $18.91 and its 200-day simple moving average is $16.57. The company has a debt-to-equity ratio of 1.79, a quick ratio of 1.64 and a current ratio of 2.94.

Hedge Funds Weigh In On Phibro Animal Health

Several institutional investors have recently modified their holdings of PAHC. Illinois Municipal Retirement Fund boosted its stake in Phibro Animal Health by 7.2% during the 1st quarter. Illinois Municipal Retirement Fund now owns 11,430 shares of the company’s stock valued at $148,000 after purchasing an additional 765 shares during the period. CWM LLC raised its holdings in shares of Phibro Animal Health by 89.8% during the second quarter. CWM LLC now owns 2,188 shares of the company’s stock valued at $37,000 after buying an additional 1,035 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its position in shares of Phibro Animal Health by 7.4% during the first quarter. Price T Rowe Associates Inc. MD now owns 15,393 shares of the company’s stock worth $200,000 after buying an additional 1,063 shares during the period. China Universal Asset Management Co. Ltd. grew its holdings in Phibro Animal Health by 65.0% in the 1st quarter. China Universal Asset Management Co. Ltd. now owns 3,888 shares of the company’s stock worth $50,000 after buying an additional 1,531 shares in the last quarter. Finally, Cardinal Capital Management increased its position in Phibro Animal Health by 4.7% in the 2nd quarter. Cardinal Capital Management now owns 56,027 shares of the company’s stock valued at $940,000 after acquiring an additional 2,520 shares during the period. Institutional investors own 99.34% of the company’s stock.

Insider Activity

In related news, Director E Thomas Corcoran purchased 5,000 shares of the company’s stock in a transaction dated Wednesday, September 4th. The shares were acquired at an average cost of $20.02 per share, for a total transaction of $100,100.00. Following the transaction, the director now owns 25,000 shares of the company’s stock, valued at $500,500. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Corporate insiders own 50.06% of the company’s stock.

Phibro Animal Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 25th. Shareholders of record on Wednesday, September 4th will be paid a $0.12 dividend. The ex-dividend date is Wednesday, September 4th. This represents a $0.48 dividend on an annualized basis and a yield of 2.18%. Phibro Animal Health’s payout ratio is currently 150.00%.

About Phibro Animal Health

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.